Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Obayashi, Konen ^a   Ueda, Mitsuharu ^a   Oshima, Toshinori ^a   Kawahara, Satomi ^a   Misumi, Yohei ^a   Yamashita, Taro ^a   Jono, Hirofumi ^a   Yazaki, Masahide ^b   Kametani, Fuyuki ^c   Ikeda, Shu Ichi ^b   Ohya, Yuki ^a   Asonuma, Katsuhiro ^a   Inomata, Yukihiro ^a   Ando, Yukio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PREALBUMIN;

ADULT; AMYLOIDOSIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; AUTOPSY; CASE REPORT; COMPLETE HEART BLOCK; FAMILIAL AMYLOID POLYNEUROPATHY; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART AMYLOIDOSIS; HEART CATHETERIZATION; HEART VENTRICLE FIBRILLATION; HISTOPATHOLOGY; HUMAN; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH BIOPSY; TONGUE AMYLOIDOSIS; VITREOUS OPACITY; WILD TYPE;

EID: 84865644264     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/BCR-2012-006593     Document Type: Article

References (15)

1. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057-62. (Pubitemid 41043725)
2. Zeldenrust S, Benson MD. Familial and senile amyloidosis caused by transthyretin. In: Alvarado M, Kelly JW, Dobson CM, eds. Protein misfolding diseases: current and emerging principles and therapies. Hoboken, NJ: John Wiley & Sons, 2010:795-815.
3. Suhr OB, Friman S, Ericzon BG. Early liver transplantation improves familial amyloidotic polyneuropathy patients' survival. Amyloid 2005;12:233- 8.
4. Yamashita T, Ando Y, Okamoto S, et al. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. Neurology 2012;78:637-43.
5. Dubrey SW, Davidoff R, Skinner M, et al. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74-80. (Pubitemid 27327203)
6. Yazaki M, Mitsuhashi S, Tokuda T, et al. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007;7:235-42. (Pubitemid 44952878)
7. Tashima K, Ando Y, Ando E, et al. Heterogeneity of clinical symptoms in patients with familial amyloidotic polyneuropathy (FAP TTR Met30). Amyloid 1997;4:108-11. (Pubitemid 127497424)
8. Takahashi K, Yi S, Kimura Y, et al. Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study. Hum Pathol 1991;22:519-27.
9. Tsuchiya A, Yazaki M, Kametani F, et al. Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl 2008;14:563-70. (Pubitemid 351524414)
10. Pitkänen P, Westermark P, Cornwell GG III. Senile systemic amyloidosis. Am J Pathol 1984;117:391-9.
11. Ueda M, Horibata Y, Shono M, et al. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study. Mod Pathol 2011;24:1533-44.
12. Koike H, Misu K, Sugiura M, et al. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 2004;63:129-38. (Pubitemid 38943790)
13. Koike H, Ando Y, Ueda M, et al. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 2009;287:178-84.
14. Morris AM, Watzky MA, Finke RG. Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Biochim Biophys Acta 2009;1794:375-97.
15. Misumi Y, Ando Y, Ueda M, et al. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy. J Pathol 2009;219:481-90.